Amdocs Net Income

DOX Stock  USD 69.70  3.43  4.69%   
As of the 11th of February 2026, Amdocs shows the mean deviation of 1.16, and Risk Adjusted Performance of (0.07). Amdocs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Amdocs Total Revenue

3.24 Billion

Amdocs' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amdocs' valuation are provided below:
Gross Profit
1.7 B
Profit Margin
0.1247
Market Capitalization
B
Enterprise Value Revenue
1.8839
Revenue
4.6 B
We have found one hundred twenty available fundamental signals for Amdocs, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Amdocs prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 6.9 B in 2026. Enterprise Value is likely to drop to about 6.6 B in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Income652.9 M366.7 M
Net Income Applicable To Common Shares631.9 M396.4 M
Net Income From Continuing Ops652.9 M540 M
Net Income Per Share 4.57  4.80 
Net Income Per E B T 0.73  0.59 
Net Income Per Share is likely to rise to 4.80 in 2026, whereas Net Income is likely to drop slightly above 366.7 M in 2026.
  
Build AI portfolio with Amdocs Stock
The evolution of Net Income for Amdocs provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Amdocs compares to historical norms and industry peers.

Latest Amdocs' Net Income Growth Pattern

Below is the plot of the Net Income of Amdocs over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Amdocs financial statement analysis. It represents the amount of money remaining after all of Amdocs operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Amdocs' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 567.77 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Amdocs Net Income Regression Statistics

Arithmetic Mean453,419,755
Geometric Mean365,323,230
Coefficient Of Variation32.78
Mean Deviation98,332,066
Median446,163,000
Standard Deviation148,642,847
Sample Variance22094.7T
Range682.5M
R-Value0.62
Mean Square Error14609T
R-Squared0.38
Significance0.01
Slope18,148,351
Total Sum of Squares353515.1T

Amdocs Net Income History

2026366.4 M
2025649.4 M
2024564.7 M
2023493.2 M
2022540.7 M
2021549.5 M
2020688.4 M

Other Fundumenentals of Amdocs

Amdocs Net Income component correlations

Amdocs Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Net Income. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. Projected growth potential of Amdocs fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Amdocs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.088
Dividend Share
2.156
Earnings Share
5.16
Revenue Per Share
41.642
Quarterly Revenue Growth
0.041
Investors evaluate Amdocs using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amdocs' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Amdocs' market price to deviate significantly from intrinsic value.
It's important to distinguish between Amdocs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Amdocs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Amdocs' market price signifies the transaction level at which participants voluntarily complete trades.

Amdocs 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amdocs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amdocs.
0.00
11/13/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/11/2026
0.00
If you would invest  0.00  in Amdocs on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Amdocs or generate 0.0% return on investment in Amdocs over 90 days. Amdocs is related to or competes with Dropbox, Akamai Technologies, Open Text, Nice, EPAM Systems, InterDigital, and Confluent. Amdocs Limited, through its subsidiaries, provides software and services worldwide More

Amdocs Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amdocs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amdocs upside and downside potential and time the market with a certain degree of confidence.

Amdocs Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amdocs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amdocs' standard deviation. In reality, there are many statistical measures that can use Amdocs historical prices to predict the future Amdocs' volatility.
Hype
Prediction
LowEstimatedHigh
71.4873.0874.68
Details
Intrinsic
Valuation
LowRealHigh
65.8285.4587.05
Details
7 Analysts
Consensus
LowTargetHigh
86.9195.50106.01
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.871.881.90
Details

Amdocs February 11, 2026 Technical Indicators

Amdocs Backtested Returns

Amdocs secures Sharpe Ratio (or Efficiency) of -0.0805, which signifies that the company had a -0.0805 % return per unit of standard deviation over the last 3 months. Amdocs exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amdocs' risk adjusted performance of (0.07), and Mean Deviation of 1.16 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.66, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amdocs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amdocs is expected to be smaller as well. At this point, Amdocs has a negative expected return of -0.14%. Please make sure to confirm Amdocs' market risk adjusted performance, jensen alpha, as well as the relationship between the Jensen Alpha and rate of daily change , to decide if Amdocs performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.78  

Almost perfect reverse predictability

Amdocs has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Amdocs time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amdocs price movement. The serial correlation of -0.78 indicates that around 78.0% of current Amdocs price fluctuation can be explain by its past prices.
Correlation Coefficient-0.78
Spearman Rank Test-0.21
Residual Average0.0
Price Variance18.56
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Amdocs Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

21.39 Million

At this time, Amdocs' Accumulated Other Comprehensive Income is fairly stable compared to the past year.
Based on the recorded statements, Amdocs reported net income of 567.77 M. This is 5.34% higher than that of the IT Services sector and significantly higher than that of the Information Technology industry. This indicator is about the same for all United States stocks average (which is currently at 5.7097980139E8).

Amdocs Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.
Amdocs is currently under evaluation in net income category among its peers.

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.
Environmental
Governance
Social

Amdocs Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.
Shares
Nordea Investment Mgmt Bank Demark A/s2025-06-30
1.9 M
Geode Capital Management, Llc2025-06-30
1.8 M
Alliancebernstein L.p.2025-06-30
1.8 M
Morgan Stanley - Brokerage Accounts2025-06-30
1.8 M
American Century Companies Inc2025-06-30
1.5 M
State Street Corp2025-06-30
1.5 M
Bank Of America Corp2025-06-30
1.3 M
Alyeska Investment Group, L.p.2025-06-30
1.3 M
Aqr Capital Management Llc2025-06-30
1.1 M
Fmr Inc2025-06-30
16.2 M
Pzena Investment Management, Llc2025-06-30
6.6 M

Amdocs Fundamentals

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.